These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 7659915)
1. [Osteopenia in primary biliary cirrhosis. Study in 20 patients]. Pumarino H; Brahm J; Oviedo S; Lillo R; González P Rev Med Chil; 1994 Dec; 122(12):1398-403. PubMed ID: 7659915 [TBL] [Abstract][Full Text] [Related]
2. Bone mineral density in rural Thai adults living in Khon Kaen province. Pongchaiyakul C; Rojroongwasinkul N; Chotmongkol R; Kosulwat V; Charoenkiatkul S; Rajatanavin R J Med Assoc Thai; 2002 Feb; 85(2):235-44. PubMed ID: 12081125 [TBL] [Abstract][Full Text] [Related]
3. A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis. Floreani A; Carderi I; Ferrara F; Rizzotto ER; Luisetto G; Camozzi V; Baldo V Dig Liver Dis; 2007 Jun; 39(6):544-8. PubMed ID: 17416215 [TBL] [Abstract][Full Text] [Related]
4. Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study. Benetti A; Crosignani A; Varenna M; Giussani CS; Allocca M; Zuin M; Podda M; Battezzati PM J Clin Gastroenterol; 2008 Mar; 42(3):306-11. PubMed ID: 18223492 [TBL] [Abstract][Full Text] [Related]
5. Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis. Camisasca M; Crosignani A; Battezzati PM; Albisetti W; Grandinetti G; Pietrogrande L; Biffi A; Zuin M; Podda M Hepatology; 1994 Sep; 20(3):633-7. PubMed ID: 8076921 [TBL] [Abstract][Full Text] [Related]
6. Long term follow up of bone mineral density in patients with primary biliary cirrhosis. Di Bisceglie AM; Loyet M; Peters M Minerva Med; 2004 Dec; 95(6):529-34. PubMed ID: 15785437 [TBL] [Abstract][Full Text] [Related]
7. Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment. Crippin JS; Jorgensen RA; Dickson ER; Lindor KD Am J Gastroenterol; 1994 Jan; 89(1):47-50. PubMed ID: 8273797 [TBL] [Abstract][Full Text] [Related]
8. [Decreased bone mineral density and gene polymorphism in primary biliary cirrhosis]. Lakatos PL; Bajnok E; Tornai I; Folhoffer A; Horváth A; Lakatos P; Szalay F Orv Hetil; 2004 Feb; 145(7):331-6. PubMed ID: 15049048 [TBL] [Abstract][Full Text] [Related]
9. [Assessment of bone status in intermittent and continuous alcoholics, without evidence of liver damage]. Pumarino H; González P; Oviedo S; Lillo R; Bustamante E Rev Med Chil; 1996 Apr; 124(4):423-30. PubMed ID: 9110481 [TBL] [Abstract][Full Text] [Related]
10. Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis. Guañabens N; Parés A; Ros I; Alvarez L; Pons F; Caballería L; Monegal A; Martínez de Osaba MJ; Roca M; Peris P; Rodés J Am J Gastroenterol; 2003 Oct; 98(10):2268-74. PubMed ID: 14572578 [TBL] [Abstract][Full Text] [Related]
11. Inadequate dietary intake but not renal tubular acidosis is associated with bone demineralization in primary biliary cirrhosis. Allocca M; Crosignani A; Gritti A; Benetti A; Zuin M; Podda M; Battezzati PM Aliment Pharmacol Ther; 2007 Jan; 25(2):219-27. PubMed ID: 17229245 [TBL] [Abstract][Full Text] [Related]
12. Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis. Guañabens N; Parés A; Ros I; Caballería L; Pons F; Vidal S; Monegal A; Peris P; Rodés J J Hepatol; 2005 Apr; 42(4):573-7. PubMed ID: 15763344 [TBL] [Abstract][Full Text] [Related]
13. Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference? Lindor KD; Janes CH; Crippin JS; Jorgensen RA; Dickson ER Hepatology; 1995 Feb; 21(2):389-92. PubMed ID: 7843710 [TBL] [Abstract][Full Text] [Related]
14. Relationship between carotid atherosclerosis and lumbar spine bone mineral density in postmenopausal women. Sumino H; Ichikawa S; Kasama S; Takahashi T; Sakamoto H; Kumakura H; Takayama Y; Kanda T; Murakami M; Kurabayashi M Hypertens Res; 2008 Jun; 31(6):1191-7. PubMed ID: 18716368 [TBL] [Abstract][Full Text] [Related]
15. [Biochemical markers of bone remodeling and bone density in healthy postmenopausal women]. Campusano C; López JM; González G; Rojas A; Arteaga E; Rodríguez J Rev Med Chil; 1993 Sep; 121(9):1000-5. PubMed ID: 8191148 [TBL] [Abstract][Full Text] [Related]
16. Bone mineral density in women with sarcoidosis. Sipahi S; Tuzun S; Ozaras R; Calis HT; Ozaras N; Tuzun F; Karayel T J Bone Miner Metab; 2004; 22(1):48-52. PubMed ID: 14691687 [TBL] [Abstract][Full Text] [Related]
17. Bone mineral affection in asymptomatic adult patients with celiac disease. Mazure R; Vazquez H; Gonzalez D; Mautalen C; Pedreira S; Boerr L; Bai JC Am J Gastroenterol; 1994 Dec; 89(12):2130-4. PubMed ID: 7977227 [TBL] [Abstract][Full Text] [Related]
18. Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves' disease. Lucidarme N; Ruiz JC; Czernichow P; Léger J J Pediatr; 2000 Jul; 137(1):56-62. PubMed ID: 10891822 [TBL] [Abstract][Full Text] [Related]
19. Bone disorders in cholestatic liver diseases. Isaia G; Di Stefano M; Roggia C; Ardissone P; Rosina F Forum (Genova); 1998; 8(1):28-38. PubMed ID: 9514992 [TBL] [Abstract][Full Text] [Related]
20. [Bone density and laboratory parameters of bone metabolism in patients with terminal heart disease]. Christ E; Linka A; Junga G; Odermatt M; Steinert H; Kiowski W; Schmid C Schweiz Med Wochenschr; 1996 Sep; 126(37):1553-9. PubMed ID: 8927958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]